Diabetes News and Research

Latest Diabetes News and Research

Eye-gaze technology opens world of communication for Rett Syndrome children

Special eye-gaze technology now being used in the Department of Neurology at The Children's Hospital at Montefiore (CHAM) is revealing the hidden, inner world of children who have Rett Syndrome, a rare and severe autism spectrum disorder that primarily affects little girls. It is a neurological disease in which mobility and autonomic functions are severely impaired, seizures and orthopedic problems are common, and the children lose functional hand use and the ability to speak.

26 Oct 2010

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.

26 Oct 2010

Salk discovers potential new target for MS

Scientists are closer to solving one of the many mysteries of multiple sclerosis and other demyelinating diseases, thanks to a recent study conducted at the Salk Institute for Biological Studies. The research revealed a previously unknown connection between two ion channels, which, when misaligned, can cause the many bizarre symptoms that characterize the condition.

26 Oct 2010

Study looks at long-term consequences of heavy smoking on dementia

Heavy smoking in midlife is associated with a 157 percent increased risk of developing Alzheimer's disease and a 172 percent increased risk of developing vascular dementia, according to a Kaiser Permanente study published in the Archives of Internal Medicine.

26 Oct 2010

Junk food taxes not the answer for childhood obesity: Report

A Productivity Commission report, “Childhood Obesity: an Economic Perspective”, released this Monday said that junk food taxes were not a cure for childhood obesity. It read, “Bans or taxes on particular energy-dense nutrient-poor foods, for example, face design difficulties, affect all consumers regardless of their weight status, and in the case of taxes, can have perverse budgetary and health effects particularly for the neediest groups.”

25 Oct 2010

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Repros Therapeutics Inc. today announced it has commenced randomization of subjects into its Phase II Androxal® study in the treatment of type 2 diabetes (T2DM) in men with low testosterone. Low testosterone and T2DM are co-morbid conditions in a significant number of men. The study is being conducted at nine sites across the US including both academic and private practices and will enroll up to 150 patients.

25 Oct 2010

FDA approves Roche's real-time PCR COBAS TaqMan HCV Test, v2.0

Roche announced today that the U.S. Food & Drug Administration (FDA) has approved the real-time PCR COBAS® TaqMan® HCV Test, v2.0. Clinical research organizations have depended on COBAS® TaqMan® technology to support hepatitis C pharmaceutical trials and development.

25 Oct 2010

Positive results from Alkermes combination Phase 1 study of ALKS 33 and buprenorphine for cocaine addiction

Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.

25 Oct 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden.

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

A study published earlier this year in the peer reviewed online journal BMC Public Health has found that residing in a neighborhood with adverse living conditions such as low air quality, loud traffic or industrial noise, or poorly maintained streets, sidewalks and yards, makes mobility problems much more likely in late middle-aged African Americans with diabetes.

25 Oct 2010

CARTaGENE database meets 20k participant milestone

This week, the last questionnaire was filled out and the final vial of blood was drawn, closing CARTaGENE's first ambitious goal of collecting samples and data from 20 000 Quebecers.

25 Oct 2010

$Precautions needed against cold-related frostbite, ankle sprains and fractures$

Precautions needed against cold-related frostbite, ankle sprains and fractures

With cold weather on the horizon, podiatrists at Temple University's School of Podiatric Medicine warn that people of all ages need to take precautions to protect their feet from cold-related injuries like frostbite, ankle sprains and fractures.

25 Oct 2010

Experts identify efficient way to increase minority access to colorectal cancer screening

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.

25 Oct 2010

New disease map resource can reduce MRSA infection in hospitalized patients

Gary A. Puckrein, Ph.D., CEO of the National Minority Quality Forum, and Gary Doern, Ph.D., nationally recognized infectious disease expert, will host the launch of the national MRSA Atlas by way of a webinar.

25 Oct 2010

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Metabolic syndrome, associated with the sedentary lifestyle and energy dense diet of Western industrialized societies, may be an indicator of breast cancer risk in post-menopausal women, according to a new study to be released at the National Italian American Foundation event, "Let's Talk About It: A Spotlight on Women's Health" on October 22nd at the Washington Hilton in Washington, D.C.

25 Oct 2010

Aortic stiffness seen in obese children

The blood vessels of obese children have stiffness normally seen in much older adults with cardiovascular disease, Dr. Kevin Harris today told the Canadian Cardiovascular Congress 2010, co-hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation. The clock is ticking and the shape of the 13 year-old-heart is changing - for the worse.

25 Oct 2010

Two researchers receive European Research Council Starting Grants

Two European Research Council (ERC) Starting Grants worth almost one and a half million euros each over the next five years have been awarded to two researchers from the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and the Charit Universit-tsmedizin, Berlin in Germany.

25 Oct 2010

Diabetes and peripheral artery disease are costly; PAD may spur growth in medical device industry

Diabetes cases in the U.S. are expected to double or triple by 2050, according to a new report by the Centers for Disease Control and Prevention.

25 Oct 2010

Arena's NDA receives Complete Response Letter for lorcaserin

Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese

25 Oct 2010

Diabetes News and Research

Latest Diabetes News and Research

Eye-gaze technology opens world of communication for Rett Syndrome children

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Salk discovers potential new target for MS

Study looks at long-term consequences of heavy smoking on dementia

Junk food taxes not the answer for childhood obesity: Report

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

FDA approves Roche's real-time PCR COBAS TaqMan HCV Test, v2.0

Positive results from Alkermes combination Phase 1 study of ALKS 33 and buprenorphine for cocaine addiction

Non communicable diseases will cost India USD237 billion during 2006-15

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

CARTaGENE database meets 20k participant milestone

Precautions needed against cold-related frostbite, ankle sprains and fractures

Experts identify efficient way to increase minority access to colorectal cancer screening

New disease map resource can reduce MRSA infection in hospitalized patients

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Aortic stiffness seen in obese children

Two researchers receive European Research Council Starting Grants

Diabetes and peripheral artery disease are costly; PAD may spur growth in medical device industry

Arena's NDA receives Complete Response Letter for lorcaserin

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in